pI: 5.5571 |
Length (AA): 762 |
MW (Da): 86394 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
431 | 746 | 4npj (A) | 377 | 652 | 18.00 | 0 | 0.96 | 0.350898 | 0.77 |
510 | 555 | 3m7f (B) | 160 | 205 | 45.00 | 0.63 | 0.05 | 0.322767 | 0.88 |
640 | 753 | 2ep6 (A) | 103 | 217 | 39.00 | 0 | 0.92 | 0.558006 | 0.02 |
640 | 747 | 3jzy (A) | 1547 | 1657 | 26.00 | 0 | 0.54 | 0.404932 | -0.4 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127860)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G11610 | C2 calcium/lipid-binding plant phosphoribosyltransferase family protein |
Arabidopsis thaliana | AT5G48060 | C2 calcium/lipid-binding plant phosphoribosyltransferase family protein |
Arabidopsis thaliana | AT3G03680 | C2 and plant phosphoribosyltransferase domain-containing protein |
Arabidopsis thaliana | AT1G51570 | calcium-dependent lipid-binding (CaLB domain) plant phosphoribosyltransferase family protein |
Arabidopsis thaliana | AT1G04150 | C2 calcium/lipid-binding plant phosphoribosyltransferase family protein |
Arabidopsis thaliana | AT5G06850 | FT-interacting protein 1 |
Arabidopsis thaliana | AT1G22610 | C2 calcium/lipid-binding plant phosphoribosyltransferase family protein |
Arabidopsis thaliana | AT3G61300 | C2 calcium/lipid-binding and phosphoribosyltransferase C-terminal domain-containing protein |
Arabidopsis thaliana | AT1G74720 | putative transmembrane protein QUIRKY |
Arabidopsis thaliana | AT4G20080 | calcium-dependent lipid-binding domain-containing plant phosphoribosyltransferase-like protein |
Arabidopsis thaliana | AT4G00700 | C2 calcium/lipid-binding plant phosphoribosyltransferase family protein |
Arabidopsis thaliana | AT5G17980 | C2 calcium/lipid-binding and phosphoribosyltransferase C-terminal domain-containing protein |
Arabidopsis thaliana | AT3G57880 | C2 domain-containing plant phosphoribosyltransferase-like protein |
Arabidopsis thaliana | AT5G12970 | calcium-dependent lipid-binding domain-containing plant phosphoribosyltransferase-like protein |
Brugia malayi | Bm1_47550 | C2 domain containing protein |
Caenorhabditis elegans | CELE_D2092.1 | Protein D2092.1, isoform A |
Drosophila melanogaster | Dmel_CG15078 | Multiple C2 domain and transmembrane region protein |
Echinococcus granulosus | EgrG_001002200 | multiple C2 and transmembrane domain containing protein |
Echinococcus granulosus | EgrG_001002000 | multiple C2 and transmembrane domain containing protein |
Echinococcus multilocularis | EmuJ_001002000 | multiple C2 and transmembrane domain containing protein |
Echinococcus multilocularis | EmuJ_001002200 | multiple C2 and transmembrane domain containing protein |
Homo sapiens | ENSG00000175471 | multiple C2 domains, transmembrane 1 |
Homo sapiens | ENSG00000140563 | multiple C2 domains, transmembrane 2 |
Loa Loa (eye worm) | LOAG_05813 | hypothetical protein |
Mus musculus | ENSMUSG00000032776 | multiple C2 domains, transmembrane 2 |
Mus musculus | 78771 | multiple C2 domains, transmembrane 1 |
Oryza sativa | 4336135 | Os04g0472900 |
Oryza sativa | 4330234 | Os02g0663900 |
Oryza sativa | 4342481 | Os07g0165100 |
Oryza sativa | 4338582 | Os05g0370600 |
Oryza sativa | 4337448 | Os04g0683800 |
Oryza sativa | 4337508 | Os04g0691800 |
Oryza sativa | 4331135 | Os02g0816000 |
Oryza sativa | 4341529 | Os06g0614000 |
Oryza sativa | 4327662 | Os01g0587300 |
Oryza sativa | 9270377 | Os12g0187575 |
Oryza sativa | 4338873 | Os05g0429700 |
Oryza sativa | 4343239 | Os07g0483500 |
Schistosoma japonicum | Sjp_0092260 | IPR000008,C2 calcium-dependent membrane targeting;IPR008973,C2 calcium/lipid-binding region, CaLB,domain-containing |
Schistosoma japonicum | Sjp_0132830 | expressed protein |
Schistosoma mansoni | Smp_130920 | mctp-related |
Trichomonas vaginalis | TVAG_485570 | synaptotagmin, putative |
Trichomonas vaginalis | TVAG_054530 | ion channel nompc, putative |
Trichomonas vaginalis | TVAG_038690 | synaptotagmin 1,2, putative |
Trichomonas vaginalis | TVAG_605770 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_D2092.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.